Login / Signup
Arsenic trioxide regulates the glycolytic pathway to treat acute promyelocytic leukemia by inhibiting RPL22L1.
Heran Cui
Yuanyang Ma
Shulin Han
Xiaodong Zhang
Weiya Fu
Shuang Yang
Tianhang Liu
Xuefang Zhang
Published in:
Leukemia research (2024)
ATO regulates the blycolytic pathway in APL by inhibiting RPL22L1 expression, and this may contribute to its therapeutic effects.
Keyphrases
</>
signaling pathway
poor prognosis
liver failure
acute myeloid leukemia
bone marrow
drinking water
respiratory failure
heavy metals
binding protein
intensive care unit